Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms
Antimicrobial drug resistance is one of the major threats to global health. It has made common infections increasingly difficult or impossible to treat, and leads to higher medical costs, prolonged hospital stays and increased mortality. Infection rates due to multidrug-resistant organisms (MDRO) ar...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118222000251 |
_version_ | 1818552484726046720 |
---|---|
author | Cheng Len Sy Pao-Yu Chen Chun-Wen Cheng Ling-Ju Huang Ching-Hsun Wang Tu-Hsuan Chang Yi-Chin Chang Chia-Jung Chang Ing-Moi Hii Yu-Lung Hsu Ya-Li Hu Pi-Lien Hung Chen-Yen Kuo Pei-Chin Lin Po-Yen Liu Ching-Lung Lo Shih-Hao Lo Pei-Ju Ting Chien-Fang Tseng Hsiao-Wei Wang Ching-Hsiang Yang Susan Shin-Jung Lee Yao-Shen Chen Yung-Ching Liu Fu-Der Wang |
author_facet | Cheng Len Sy Pao-Yu Chen Chun-Wen Cheng Ling-Ju Huang Ching-Hsun Wang Tu-Hsuan Chang Yi-Chin Chang Chia-Jung Chang Ing-Moi Hii Yu-Lung Hsu Ya-Li Hu Pi-Lien Hung Chen-Yen Kuo Pei-Chin Lin Po-Yen Liu Ching-Lung Lo Shih-Hao Lo Pei-Ju Ting Chien-Fang Tseng Hsiao-Wei Wang Ching-Hsiang Yang Susan Shin-Jung Lee Yao-Shen Chen Yung-Ching Liu Fu-Der Wang |
author_sort | Cheng Len Sy |
collection | DOAJ |
description | Antimicrobial drug resistance is one of the major threats to global health. It has made common infections increasingly difficult or impossible to treat, and leads to higher medical costs, prolonged hospital stays and increased mortality. Infection rates due to multidrug-resistant organisms (MDRO) are increasing globally. Active agents against MDRO are limited despite an increased in the availability of novel antibiotics in recent years. This guideline aims to assist clinicians in the management of infections due to MDRO. The 2019 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, comprising of infectious disease specialists from 14 medical centers in Taiwan, reviewed current evidences and drafted recommendations for the treatment of infections due to MDRO. A nationwide expert panel reviewed the recommendations during a consensus meeting in Aug 2020, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes recommendations for selecting antimicrobial therapy for infections caused by carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, carbapenem-resistant Enterobacterales, and vancomycin-resistant Enterococcus. The guideline takes into consideration the local epidemiology, and includes antimicrobial agents that may not yet be available in Taiwan. It is intended to serve as a clinical guide and not to supersede the clinical judgment of physicians in the management of individual patients. |
first_indexed | 2024-12-12T09:13:48Z |
format | Article |
id | doaj.art-d6b8767d5832434ea86b452caeac02dd |
institution | Directory Open Access Journal |
issn | 1684-1182 |
language | English |
last_indexed | 2024-12-12T09:13:48Z |
publishDate | 2022-06-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Microbiology, Immunology and Infection |
spelling | doaj.art-d6b8767d5832434ea86b452caeac02dd2022-12-22T00:29:27ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822022-06-01553359386Recommendations and guidelines for the treatment of infections due to multidrug resistant organismsCheng Len Sy0Pao-Yu Chen1Chun-Wen Cheng2Ling-Ju Huang3Ching-Hsun Wang4Tu-Hsuan Chang5Yi-Chin Chang6Chia-Jung Chang7Ing-Moi Hii8Yu-Lung Hsu9Ya-Li Hu10Pi-Lien Hung11Chen-Yen Kuo12Pei-Chin Lin13Po-Yen Liu14Ching-Lung Lo15Shih-Hao Lo16Pei-Ju Ting17Chien-Fang Tseng18Hsiao-Wei Wang19Ching-Hsiang Yang20Susan Shin-Jung Lee21Yao-Shen Chen22Yung-Ching Liu23Fu-Der Wang24Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, TaiwanDivision of General Medicine, Infectious Diseases, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, TaiwanDivision of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, TaiwanDepartment of Pediatrics, Chi-Mei Medical Center, Tainan, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanDepartment of Pediatrics, MacKay Children's Hospital and MacKay Memorial Hospital, Taipei, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Changhua Christian Hospital, Changhua, TaiwanDivision of Pediatric Infectious Diseases, China Medical University Children's Hospital, China Medical University, Taichung, TaiwanDepartment of Pediatrics, Cathay General Hospital, Taipei, TaiwanDepartment of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, TaiwanDepartment of Pediatrics, Chang Gung Children's Hospital, College of Medicine, Chang Gung University College of Medicine, Taoyuan, TaiwanDepartment of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Pharmacy, School of Pharmacy, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, TaiwanDepartment of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, TaiwanDivision of Infectious Diseases, Department of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pediatrics, MacKay Children's Hospital and MacKay Memorial Hospital, Taipei, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, TaiwanDepartment of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Corresponding author. Kaohsiung Veterans General Hospital, School of Medicine, National Yang Ming Chiao Tung University Division of Infectious Diseases, Department of Internal Medicine 365, Ta-chung 1st Rd, Kaohsiung 813 Taipei Taiwan.Fax: +886 7 346 8296Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDivision of Infectious Diseases, Taipei Medical University Shuang Ho Hospital, Taipei, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, TaiwanAntimicrobial drug resistance is one of the major threats to global health. It has made common infections increasingly difficult or impossible to treat, and leads to higher medical costs, prolonged hospital stays and increased mortality. Infection rates due to multidrug-resistant organisms (MDRO) are increasing globally. Active agents against MDRO are limited despite an increased in the availability of novel antibiotics in recent years. This guideline aims to assist clinicians in the management of infections due to MDRO. The 2019 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, comprising of infectious disease specialists from 14 medical centers in Taiwan, reviewed current evidences and drafted recommendations for the treatment of infections due to MDRO. A nationwide expert panel reviewed the recommendations during a consensus meeting in Aug 2020, and the guideline was endorsed by the Infectious Diseases Society of Taiwan (IDST). This guideline includes recommendations for selecting antimicrobial therapy for infections caused by carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, carbapenem-resistant Enterobacterales, and vancomycin-resistant Enterococcus. The guideline takes into consideration the local epidemiology, and includes antimicrobial agents that may not yet be available in Taiwan. It is intended to serve as a clinical guide and not to supersede the clinical judgment of physicians in the management of individual patients.http://www.sciencedirect.com/science/article/pii/S1684118222000251CRECRABVREMDROCRPAGuideline |
spellingShingle | Cheng Len Sy Pao-Yu Chen Chun-Wen Cheng Ling-Ju Huang Ching-Hsun Wang Tu-Hsuan Chang Yi-Chin Chang Chia-Jung Chang Ing-Moi Hii Yu-Lung Hsu Ya-Li Hu Pi-Lien Hung Chen-Yen Kuo Pei-Chin Lin Po-Yen Liu Ching-Lung Lo Shih-Hao Lo Pei-Ju Ting Chien-Fang Tseng Hsiao-Wei Wang Ching-Hsiang Yang Susan Shin-Jung Lee Yao-Shen Chen Yung-Ching Liu Fu-Der Wang Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms Journal of Microbiology, Immunology and Infection CRE CRAB VRE MDRO CRPA Guideline |
title | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
title_full | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
title_fullStr | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
title_full_unstemmed | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
title_short | Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
title_sort | recommendations and guidelines for the treatment of infections due to multidrug resistant organisms |
topic | CRE CRAB VRE MDRO CRPA Guideline |
url | http://www.sciencedirect.com/science/article/pii/S1684118222000251 |
work_keys_str_mv | AT chenglensy recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT paoyuchen recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chunwencheng recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT lingjuhuang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chinghsunwang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT tuhsuanchang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT yichinchang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chiajungchang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT ingmoihii recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT yulunghsu recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT yalihu recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT pilienhung recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chenyenkuo recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT peichinlin recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT poyenliu recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chinglunglo recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT shihhaolo recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT peijuting recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chienfangtseng recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT hsiaoweiwang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT chinghsiangyang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT susanshinjunglee recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT yaoshenchen recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT yungchingliu recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms AT fuderwang recommendationsandguidelinesforthetreatmentofinfectionsduetomultidrugresistantorganisms |